S&P Biotech SPDR (XBI)

$116.24 1.26 (1.10%)

20:00 EDT XBI Stock Quote Delayed 30 Minutes

Volume:

Previous Close $116.24

Market Cap 6.28B

PE Ratio -

EPS -

Volume (Avg. Vol.) 5.98M

Day's Range 113.16 - 116.33

52-Week Range 62.94 - 121.06

Dividend & Yield 0.23 (0.19%)

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

From InvestorPlace
From the Web

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor Sep 18, 2020

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

By Todd Shriber, InvestorPlace Contributor Aug 4, 2020

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

3 Top Drug Stocks to Own In 2020

By Ian Cooper Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

Compare Brokers

4 Top Stock Trades for Friday: MU, Biotech, Bitcoin

By Bret Kenwell, InvestorPlace Contributor Sep 26, 2019

Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.

Hexo Stock Is Down — But Not Out

By Nicolas Chahine, InvestorPlace Contributor Sep 4, 2019

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best SPDR ETFs — Besides SPY and GLD

By Todd Shriber, InvestorPlace Contributor Jul 3, 2019

SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.

Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle

By Bret Kenwell, InvestorPlace Contributor Jun 27, 2019

Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.

IBB is up Over 5%, But the Market May Retest its Lows

By Ken Trester Jan 7, 2019

This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Compare Brokers

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

10 Best ETFs for 2018: Still a Close Race at the Head of the Pack

By Jessica Loder, InvestorPlace Assistant Editor Oct 10, 2018

As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.

10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint

By Jessica Loder, InvestorPlace Assistant Editor Jul 11, 2018

As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.

Biotech ETFs Are the Best Way to Play the Recovering Sector

By Chris Lau, InvestorPlace Contributor May 30, 2018

The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.

10 Best ETFs for 2018: A Tumultuous First Quarter

By Jessica Loder, InvestorPlace Assistant Editor Apr 3, 2018

While some of the contenders have been gravitating toward the top or bottom, it's still very much anyone's game in the Best ETFs for 2018 contest.

3 Bullish Options Trades to Buy the Weakness

By Tyler Craig, Tales of a Technician Mar 19, 2018

A phase of weakness has hit Wall Street, but the dip could be a buy. Here are three bullish options trades to consider in V, BIDU and XBI.

Compare Brokers

3 Ways to Profit from the Market Panic

By Tyler Craig, Tales of a Technician Feb 5, 2018

On Friday, volatility went up while the stocks mostly went down. Looking to cash in on the movement? Try these options for XBI, XLE and EEM.

10 Best ETFs for 2018: Funds at the Starting Line

By Jessica Loder, InvestorPlace Assistant Editor Jan 18, 2018

Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.

Don’t Count Bank Stocks Out Just Yet. For One Thing, They’re Cheap.

From Barron's Sep 19, 2020

“We wonder if the risk of not owning U.S. bank stocks is greater than owning them,” writes Barclays’ Jason Goldberg.

Big investors should demand that banks hold more capital, Kashkari says (NYSE:JPM)

From Seeking Alpha Sep 18, 2020

Minneapolis Fed President Neel Kashkari urges big investors who own shares in and trade with the U.S.'s largest banks to push lenders to boost capital levels in order to reduce risks in the financial system."If the largest pension plans in America got together and said we aren't going to trade with banks that do not have at least 24% equity, they would increase their capital levels," he said in remarks at a virtual event held by the Council of Institutional Investors.The organization is comprised of large investors managing ~$4T of assets for pension funds, endowments, and foundations.Kashkari has been advocating for higher capital requirements since he took his role as head of the Minneapolis Fed in 2016.

S&P Biotech SPDR (XBI)

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

Subscriber Sign in